| Pharmaceutical active ingredients: |
| Guanidine |
| Available forms, composition and doses of Imidourea: |
| N / A |
| Imidourea medical category: |
| Human:Guanine oxidation derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02CC - Guanidine derivativesC02DG - Guanidine derivatives |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Imidamine | Antazoline | Unidentified Pharmaceutical Company |
| Imidan | Thalidomide | Unidentified Pharmaceutical Company |
| Imidan Peyta | Thalidomide | Unidentified Pharmaceutical Company |
| Imidene | Thalidomide | Unidentified Pharmaceutical Company |
| Imidobenzyle | Imipramine | Unidentified Pharmaceutical Company |
| Imidurea | Imidazolidinyl Urea | Unidentified Pharmaceutical Company |
| Imilanyle | Imipramine | Unidentified Pharmaceutical Company |
| Iminazole | Imidazole | Unidentified Pharmaceutical Company |
| Iminourea | Guanidine | Unidentified Pharmaceutical Company |
| Imizin | Imipramine | Unidentified Pharmaceutical Company |